Status:
UNKNOWN
Determination of Predictive Clinical Signs of Effective Rhizolysis Using the DFL Questionnaire.
Lead Sponsor:
Ramsay Générale de Santé
Collaborating Sponsors:
Dr BARAT
Conditions:
Rhizolysis
Diagnosis of Facet Joint Origin Lumbago
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rhizolysis or lumbar thermocoagulation is a therapeutic proposal for certain types of chronic lower back pain that is resistant to medical treatment and outside the field of surgical indications. A p...
Detailed Description
The frequency of chronic lower back pain is a major economic and social problem. Indeed, there are numerous solutions that can be offered to patients, but sometimes they are unsatisfactory as medical ...
Eligibility Criteria
Inclusion
- Patient suffering from chronic lower back pain developing for more than 6 months and resistant to the medical treatments.
- Patients with an indication of lumbar rhizolysis for their chronic lower back pain with a facet component, the starting point of which corresponds to the L4L5 and/or L5S1 stages.
- Patient not objecting to their participation in the study.
- Subject registered with a social security scheme
Exclusion
- Adults under judicial protection
- Adult under guardianship or trusteeship
- Pregnant women
- Minors
Key Trial Info
Start Date :
December 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04118218
Start Date
December 12 2017
End Date
March 31 2020
Last Update
October 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clairval Private Hospital
Marseille, PACA, France, 13009